Animal Planet, KONG, ORIJEN, Pedigree and Whiskas Among 92 Winners of the 2017 Animalis Edition of the World Branding Awards
The Animalis edition of the prestigious World Branding Awards saw 92 brands from 35 countries named “Brand of the Year” in a glittering ceremony held at the Hofburg Palace in Vienna today. The Animalis edition of the Awards focused on pet and animal brands.
Animal Planet, FURminator, Hill's Prescription Diet, KONG, ORIJEN, Pedigree, Petplan, PURINA Pro Plan, Red Dingo, Tetra and Whiskas were announced as global winners. Regional winners were Equi-Trek (United Kingdom), Evidensia (Sweden), Fressnapf | Maxi Zoo (Germany) and Horze (Finland).
National tier winners included V.I.P. Petfoods (Australia), Aeon Pet (Japan), Amiguard (Switzerland), Avanti (India), Benelux (Belgium), CP Prima (Indonesia), Cunipic Alpha Pro (Spain), Dolina Noteci (Poland), Dubai Aquarium & Underwater Zoo (United Arab Emirates), Earth Rated (Canada), Equsana (Denmark), Irish Rover (Ireland), JerHigh (Thailand), JUWEL Aquarium (Germany), Lord Lou (Netherlands), Manfred of Sweden (Sweden), MONGE (Italy), MUSH (Finland), NatureBridge (China), Oasy (San Marino/Italy), Pet Lovers Centre (Singapore), PetCenter (Czech Republic), Pets At Home (United Kingdom), Pi-Pi-Bent (Russia), Powercat (Malaysia), Puppia (South Korea), Q-Pets (Hong Kong), Rogz (South Africa), Royal Canin (France), Top Breed (Philippines), Vetmeduni Vienna (Austria), YU (Taiwan) and Ziwi Peak (New Zealand), among others.
Four NGOs – the Borneo Orangutan Survival Foundation (Indonesia), The David Sheldrick Wildlife Trust (Kenya), The Jane Goodall Institute (United States) and Wildlife Friends Foundation (Thailand) – were also recognised for their work.
The Awards celebrates the achievements of some of the greatest brands around the globe. Uniquely, winners are judged through three streams: brand valuation, consumer market research, and public online voting. Each brand was named “Brand of the Year” in their respective categories.
The Awards is organised by the World Branding Forum, a global non-profit organisation dedicated to advancing branding standards for the good of the branding community as well as consumers. It organises and sponsors a range of educational programmes, and has joint collaborations with leading universities and museums. The Forum also publishes branding news on its website that reaches a global audience of over 4 million visitors.
“The Animalis edition of the Awards pays tribute to the achievements of pet and animals brands from around the world. Consumer votes count towards 70 per cent of the final score, so winning brands have to have built a strong relationship with their customers in order to win,” said Richard Rowles, Chairman of the World Branding Forum.
“Over 60,000 pet and animal lovers from around the world voted for more than 800 brands from 35 countries. Winning brands have had to work hard to stand out from the tough competition,” said Peter Pek, Chief Executive of the Forum.
The event was hosted by Stuart Freeman from Radio FM4 in Austria. For more information and the full list of winners, visit awards.brandingforum.org.
About the World Branding Forum
The World Branding Forum (WBF) is a registered global non-profit organisation. Its aims and activities are to provide raise the standards of branding for the good of the industry as well as consumers. The WBF produces, manages and supports a wide range of programmes covering research, development, education, recognition, networking and outreach. For more information, visit brandingforum.org.
About the World Branding Awards
The World Branding Awards is the premier awards of the World Branding Forum, a registered non-profit organisation. The awards recognises the achievements of some of the world’s best brands. There are three major tiers of awards – the Global Award is awarded to international brands, Regional Award for brands that cover a geographic region, while the National Award is awarded to brands that are household names in their country of origin. For more information, visit https://awards.brandingforum.org.
World Branding Forum
+44 (0) 20 3743 9880
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Tilaa tiedotteet sähköpostiisi
Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme tältä julkaisijalta, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.
Lue lisää julkaisijalta Business Wire
OTEZLA® (Apremilast) Phase III Data Showed Significant Improvements in Patients with Active Behçet’s Disease with Oral Ulcers18.2.2018 00:00 | Tiedote
Celgene Corporation (NASDAQ:CELG) today announced that data from the phase III RELIEF™ clinical trial of OTEZLA® (apremilast) in patients with active Behçet’s Disease with oral ulcers were presented in a late-breaking oral presentation at the 2018 American Academy of Dermatology (AAD) Annual Meeting. The results showed statistically significant reductions in oral ulcers with apremilast 30 mg twice daily (BID) versus placebo through week 12. OTEZLA (apremilast) is Celgene’s oral selective inhibitor of phosphodiesterase 4 (PDE4). Behçet’s Disease is a rare, chronic, multi-system inflammatory syndrome. Oral ulcers, the most common manifestation of Behçet’s Disease, can be disabling and have a substantial effect on quality of life. This study primarily evaluated the effect of apremilast on recurring oral ulcers in patients with active Behçet’s Disease who were previously treated with at least one topical or systemic medication. “Reducing oral ulcers, which are painful and can negatively im
CT-P13 (biosimilar infliximab) is comparable to reference infliximab and adalimumab in highly anticipated real-world study17.2.2018 11:00 | Tiedote
Twelve-month data from the Personalised Anti-TNF therapy in Crohn’s disease Study (PANTS) was presented at the 13th Congress of the European Crohn’s and Colitis Organisation (ECCO). The results indicate that the clinical effectiveness, safety and immunogenicity of Celltrion Healthcare’s CT-P13 (biosimilar infliximab) in patients with Crohn’s disease (CD) is comparable to those treated with reference infliximab as well as those treated with adalimumab.1 The UK-wide, three-year prospective observational study investigated primary non-response (PNR), loss of response (LOR) and adverse drug reactions (ADR) to infliximab (reference infliximab and CT-P13) and adalimumab in 1610 CD patients. The data show comparable efficacy between CT-P13, reference infliximab and adalimumab in relation to PNR, LOR and ADR rates. In addition, at week 54, the remission rate was 39.7%, 39.0% and 32.7% for reference infliximab, CT-P13 and adalimumab treated patients, respectively.1 The PANTS study investigates
Avanti Communications HYLAS 4 Satellite Arrives in French Guiana16.2.2018 21:26 | Tiedote
Avanti Communications Group plc (“Avanti”), a leading provider of satellite data communications services in Europe, the Middle East and Africa (“EMEA”), announces its HYLAS 4 satellite has arrived safely in French Guiana ahead of its March 2018 launch. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180216005586/en/ Avanti Communications HYLAS 4 Satellite Arrives in French Guiana (Photo: Business Wire) The spacecraft, built by Orbital ATK was packed and shipped at their Satellite Manufacturing Facility in Dulles, Virginia, United States and flown to French Guiana, where it was unloaded and will be taken to the Arianespace launch facilities in Kourou. HYLAS 4 uses the latest High Throughput Satellite technology, doubling Avanti's Ka-band capacity across EMEA. The latest addition to Avanti's HYLAS fleet will provide: Backhaul services for mobile network operators Wholesale broadband for ISPs Connectivity for governments (civil a
General Cable Corporation Stockholders Approve Acquisition By Prysmian Group16.2.2018 20:05 | Tiedote
General Cable Corporation (NYSE: BGC) today announced the voting results from the Company’s special meeting of stockholders held this morning. Stockholders of General Cable approved the Company’s previously announced acquisition by Prysmian Group (BIT: PRY) for $30.00 per share in cash. A total of 38,140,754 shares, representing approximately 75.34% of the total number of shares of common stock outstanding and approximately 99% of the total votes cast, were voted in favor of the merger. Subject to regulatory approvals and other customary closing conditions, the transaction is expected to close by the third quarter of 2018. About General Cable General Cable (NYSE:BGC), with headquarters in Highland Heights, Kentucky, is a global leader in the development, design, manufacture, marketing and distribution of aluminum, copper and fiber optic wire and cable products for the energy, communications, automotive, industrial, construction and specialty segments. General Cable is one of the larges
Systemic Sclerosis World Congress:Inspirational Patient Stories Reveal the Challenging Realities of Living with Devastating Rare Disease16.2.2018 12:03 | Tiedote
Boehringer Ingelheim today unveils a new phase of 'More Than Scleroderma: The Inside Story', and launches the new patient website www.morethanscleroderma.com. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180216005188/en/ Anna, 36, living with scleroderma (Photo: Business Wire) The global initiative highlights the importance of understanding the ‘inside story’ of each individual living with scleroderma, also known as systemic sclerosis. To coincide with the Systemic Sclerosis World Congress in Bordeaux, 15-17 February 2018, new and truly inspiring patient stories are revealed, reflecting the real-life, diverse and very moving journeys of people living with scleroderma across the world. The campaign will also be launched in the U.S. The new website www.morethanscleroderma.com features a powerful collection of photographs and video stories of people living with scleroderma across the world, revealing the life-changing impact o
Philip Morris International Recognized as a Global Top Employer for the Second Year in a Row16.2.2018 11:00 | Tiedote
Philip Morris International Inc. (PMI) (NYSE/Euronext Paris: PM) today is recognized for the second year in a row as a Global Top Employer. This year’s certification from the Top Employer Institute is awarded to PMI teams in 44 countries, a testament to the company’s consistency and excellence in offering an enriching and dynamic work environment, and exceptional development opportunities for employees across the globe. PMI has been recognized by the Top Employer Institute for six consecutive years. This year, PMI was awarded with five regional certifications in Europe, the Middle East, Africa and, for the first time, in North America and Latin America. Additionally, Indonesia was the first PMI affiliate to be certified in Asia. “It is a proud moment for all of us at PMI,” said Charles Bendotti, PMI Senior Vice President, People and Culture. “Our success as a company relies on the men and women who come to work every day with a passion to achieve, and a willingness to learn, grow, and
Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.Tutustu uutishuoneeseemme